Skip to main content Skip to footer

Texas Immuno-Oncology Biorepository (TIOB)

Baylor Scott & White Research Institute

The Texas Immuno-Oncology Biorepository (TIOB) is a research facility that collects, catalogs and stores samples of biological material, such as urine, blood, stool, tissue, cells, DNA, RNA and protein, in an effort to improve our understanding of cancer

Our goal with the TIOB is to help researchers:

  • Analyze how different cells and immune systems respond to cancer treatment
  • Address why a cancer is resistant to treatment in some patients or why it returns in others
  • Study how to improve patient outcomes and survival rates
{6}

How is this different from other cancer research?

The TIOB was created to fuel research efforts, not to compete with them.

 

Research has led to the creation of many immunotherapies, like CAR-T, to help treat different cancers. We want to improve the understanding about how immunotherapies are performing in a real-world setting.

Through Baylor Scott & White Research Institute (BSWRI), we can safely collect biospecimens from a very large, and uniquely diverse, patient population. Those samples can then be studied with the purpose of improving and increasing the types of immunotherapies available.

The data and biological samples we gather will allow researchers to dig into the microscopic nuances that can change how one patient responds to a treatment compared with another, or what small changes can be made to improve the effectiveness of a treatment option.

Cancer Care

Advanced cancer treatment through innovative, groundbreaking therapies and research

Who can participate?

  • Patients with confirmed or suspected cancer
  • Patients who expect to receive immunotherapy
  • Patients willing to donate blood and other biospecimen samples
  • Cancer types: skin, lung, breast, liver, kidney and bladder
{6}

How it works

  1. Start Patient gives written consent
  2. First Baseline samples including urine, blood and stool are collected, and possibly tissue biopsy (if indicated)
  3. Next The patient receives FDA-approved checkpoint inhibitors/CAR-T
  4. 3 months After 3 months more samples are collected
  5. 6 months After 6 months more samples are collected
  6. Then Sample collection continues every 3 months (Unless consent is withdrawn)

    If disease progresses, sample collection will continue with treatment as directed

Frequently asked questions

 

Samples will vary by patient, but the type of samples we could collect include:

  • Tissue
  • Stool
  • Blood cells
  • Urine
  • Bodily fluids

Sample and data collection frequency will vary depending on the participant's stage of cancer, and may change with any recession or progression. Frequency can range from every 3 months to once a year. Wherever possible, the TIOB team will schedule these appointments to coincide with routine cancer therapy follow-up visits or regular visits.

Participants can withdraw at any time. There is no obligation to continue if you change your mind or are unable to continue providing samples for any reason.

Baylor Scott & White Research Institute's extensive network of team members are located at hospitals and clinics throughout Baylor Scott & White Health. Participation will be offered at facilities with a trained tissue coordinator or other BSWRI study personnel present to consent, collect, process, and appropriately transport samples.

No. Your participation is voluntary, and for research purposes only.

No. The test results are for research (not clinical) use only.

No, there are no fees associated with participation. Participants will not be billed for any biospecimen collection and lab analyses that are not related to their existing physician-prescribed care.

We want to hear from you if you are interested in connecting with us or if you have any questions, comments or concerns

 

Baylor Scott & White Research Institute
Texas Immuno-Oncology Biorepository (TIOB)

4236 Lowes Drive, Temple, TX 7650275246
888.50RESEARCH

Contact us

Scroll To Top